Merck & Co. Inc. (MRK)

  101.40
   
  • Change Today:
     0.00
  • 52 Week High:  101.40
  • 52 Week Low:  101.40
  • Currency: Euro
  • Shares Issued: 2,581.62m
  • Volume: 0
  • Market Cap:  261,776m

MRK Overview

US drugmaker, Merck & Co, is a leading global research-driven pharmaceutical products and services company. The company discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Its products, generally sold by prescription, include therapeutic and preventive agents for the treatment of human disorders and animal health supplies. The company’s products are sold, primarily, to drug wholesalers and retailers, hospitals, clinics, government agencies and managed healthcare providers, such as health maintenance organisations and other institutions.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 2.7%
Div Cover 2.2
Op Mrgn 31.1%
ROCE 43.9%
Latest F'cast
P/E 17.0
PEG 0.0
Pr/Revenue 4.6
Pr/Book 6.4
Latest F'cast
Revenue 6.7%
PBT 955.4%
EPS 4728.6%
DPS 5.4%

MRK Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 47,994.00 8,791.00 179.00¢ 41.9 n/a -53% 248.00¢ 3.3%
31-Dec-21 48,704.00 13,879.00 488.00¢ 15.9 0.1 +173% 264.00¢ 3.4%
31-Dec-22 59,283.00 16,444.00 573.00¢ 20.8 1.2 +17% 280.00¢ 2.3%
31-Dec-23 60,115.00 1,889.00 14.00¢ 825.2 n/a -98% 296.00¢ 2.6%
31-Dec-24 64,168.00 19,936.00 676.00¢ 17.1 0.0 +4,729% 312.00¢ 2.7%

MRK Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 65,065.54 27,289.76 896.08¢ 12.9 0.4 +33% 325.91¢ 0.0%
31-Dec-26 69,169.09 29,834.42 986.24¢ 11.7 1.2 +10% 342.67¢ 0.0%
31-Dec-27 73,132.59 32,676.88 1,097.07¢ 10.5 0.9 +11% 366.91¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

MRK ShareCast News

Merck in talks to buy Harpoon Therapeutics for a... 08-Jan-2024 ShareCast
Merck shares fall as FDA pauses new patients on ... 12-Apr-2023 ShareCast
Merck afirma que las prescripciones para el Covi... 03-Feb-2022 ShareCast

MRK Top Newspaper Links

Merck increases antibiotic offering with $9.5bn ... 09-Dec-2014 Telegraph
Reckitt Benckiser bows out of race for Merck's c... 01-May-2014 Telegraph
Patents Ending, Eli Lilly Chases New Drugs 01-Oct-2010 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

MRK Market Data

Currency Euro
Share Price   101.40
Change Today   0.00
% Change 0.00 %
52 Week High  101.40
52 Week Low  101.40
Volume 0
Shares Issued 2,581.62m
Market Cap  261,776m

What The Brokers Say

Strong Buy 9
Buy 6
Neutral 9
Sell 0
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @  0.00

Top of Page